- Tags: cornea
Products
Haag-Streit launches corneal map for the Lenstar 900
The optical biometer’s newest integratable feature enables simultaneous measurement of a wider range of biometric parameters for cataract surgery planning.
Pipeline
Allotex submits IDE to FDA for collagen-based corneal implant
Company is seeking to conduct a U.S. clinical trial on its tissue addition technology procedure that augments the cornea using precision-shaped human collagen.
Research
ADHD medication may lead to corneal cell changes in pediatric patients
Study notes differences in key parameters of corneal and retinal health in patients taking methylphenidate.
Business
Allotex names new CEO to lead commercialization of allogeneic corneal tissue technology
Co-founder Michael Mrochen, PhD, will assume leadership as the startup seeks an IDE for its biocompatible procedure for vision correction.
Products
B+L launches Zenlens CHROMA HOA scleral contact lenses
Newest addition to the scleral lens brand features a custom-designed, wavefront-guided scleral lens technology intended to correct advanced HOA.
Pipeline
FDA grants Fast Track designation to OKYO Pharma's NCP therapeutic
New status gives urcosimod an expedited pathway toward potential market approval as first approved treatment for this patient base.
Research
Could a CXL and customized PRK combo provide better keratoconus outcomes?
Literature review finds combined procedure provides superior visual acuity and quality.
Business
Voiant acquires AI-based ophthalmic image analysis startup Voxeleron
Software and clinical trial expertise to combine into an AI-based integrated platform for retinal and corneal imaging, with a goal of expedited patient treatment delivery.
Pipeline
OKYO's urcosimod demonstrates long-term stability for NCP
With a real-world study ongoing, urcosimod’s +2.5-year shelf stability further supports a potential NDA submission for regulatory approval down the road.
Business
Pantheon Vision and Eyedeal Medical to develop bioengineered corneal implant
Collaboration involves advancement and commercialization of Pantheon’s artificial cornea as the company nears a potential premarket approval submission.
Business
Alcon purchases majority stake in Aurion Biotech
Company replaces CEO and founder Greg Kunst, gaining access to groundbreaking CED cell therapy with plans for phase 3 clinical trials expected later this year.
Research
Rare tooth-in-eye surgery restores vision in the blind
First patients in Canada undergo osteo-odonto keratoprosthesis to regain eyesight after severe corneal blindness.
Pipeline
OKYO Pharma seeks Fast Track designation for NCP candidate
Designation would give urcosimod (formerly OK-101) an expedited pathway to potentially become the first approved treatment for this orphan disease.
Pipeline
FDA accepts NDA submission for Glaukos's Epioxa
Epi-on CXL iLink therapy could become the first noninvasive procedure with no need for corneal epithelium removal to treat keratoconus eyes.
Events
First-ever Corneal Health Summit kicks off in April
A virtual one-day event for optometrists to feature industry-leading clinical experts, COPE-accredited sessions, and free CE credits.
Business
TECLens raises $9.3M in funding for non-invasive refractive tech
The company's corneal CXL-based, non-incisional refractive correction procedure is designed to reshape the corneal for presbyopes and myopes.
Pipeline
Pantheon Vision reports positive pre-clinical FDA meeting on bioengineered corneal implants
This marks the third-presubmission meeting as the company advances clinical development of a potential alternative to corneal transplants.
Business
VisiRose raises $3M to advance RB-PDAT therapeutic toward regulatory approval
Funding will support ongoing clinical development of photodynamic therapy candidate for infectious keratitis and future IND submission to FDA.
Products
FDA approves Zeiss MEL 90 excimer laser
Integrated with the company’s Corneal Refractive Workflow, this laser system is indicated to reduce or eliminate myopia, hyperopia, and mixed astigmatism.
Products